25 Million euro for technological topresearch
Prof.dr. H.B.J. Karperien, Universiteit Twente
AMC Amsterdam, ArthroSave, BioVolt, Erasmus MC, Hy2Care, IBIS Technologies, InGell Labs, LifeTec Group, Maastricht UMC+, Percuros, QVQ Holding, Radboudumc, Reumafonds, SSens, TETEC, UMC Utrecht, University of Twente, University Utrecht, Waters, Zimmer Biomet
There is no cure for osteoarthritis. This is stated in all textbooks and it was already stated by the world-famous Scottish anatomist William Hunter in the paper he published in 1743 on ‘the structure and diseases of articulating cartilages’. According to the research consortium William Hunter Revisited the time has come to revise this statement. The group of researcher and companies with support of the Dutch osteoarthritis foundation intends to develop new methods to stop osteoarthritis from further progressing. Based on the newest developments concerning; smart biomaterials, cell cultures, laboratory animals and patients, researchers believe it is even possible to regenerate the cartilage. The consortiums first aim is to develop a repair treatment that is ready for clinical use. Secondly, they want to develop a new (early) diagnostic tool for better monitoring of the affected joint.